Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of perioperative dexamethasone dose on postoperative blood glucose in elective abdominal surgery
IRCT20120814010599N13Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in corticosteroid-induced hyperglycemia (GIH) (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Blood glucose concentration at 6 hours after dexamethasone or placebo administration and Blood glucose concentration at 24 hours after dexamethasone or placebo administration. Started Dec 2017; status: completed.
02
Drugs
dexamethasone
03
Conditions
corticosteroid-induced hyperglycemia (GIH)
Beyond the preview
Go deeper on IRCT20120814010599N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120814010599N13.